About: Prescription Drug Marketing Act

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Prescription Drug Marketing Act Goto Sponge NotDistinct Permalink

An Entity of Type : yago:YagoPermanentlyLocatedEntity, within Data Space : dbpedia.org associated with source document(s)
QRcode icon

http://dbpedia.org/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FPrescription_Drug_Marketing_Act

The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals and is designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.

Attributes	Values
rdf:type	agent yago:WikicatUnitedStatesStatutesThatAbrogateSupremeCourtDecisions yago:Abstraction100002137 yago:Act100030358 yago:Action100037396 yago:Choice100161243 yago:CivilLaw108453464 yago:Collection107951464 yago:Decision100162632 yago:Event100029378 yago:Group100031264 yago:Law108441203 yago:Legislation106535222 yago:PsychologicalFeature100023100 yago:YagoPermanentlyLocatedEntity
rdfs:label	قانون تسويق الأدوية الموصوفة طبيا (ar) Prescription Drug Marketing Act (en)
rdfs:comment	قانون تسويق الأدوية الموصوفة طبيًا (PDMA) لعام 1987 (القانون العام 100-293، المجلد 102 من مجموعة تشريعات الكونغرس الأمريكي 95) هو أحد قوانين الحكومة الفيدرالية للولايات المتحدة. ويوفر هذا القانون ضمانات قانونية تنظم توزيع الأدوية الموصوفة طبيًا للتأكد من توفير الدواء الآمن والفعال. وقد تمت صياغة هذا القانون لمكافحة بيع الدواء المزيف والمغشوش وذي العلامة التجارية المزيفة والأقل فعالية والمنتهي الصلاحية. وتم تمريره كنوع من أنواع الاستجابة لتطور سوق جملة غير قانوني (والمعروف باسم "السوق السوداء") للأدوية الموصوفة طبيًا. (ar) The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals and is designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs. (en)
dcterms:subject	Pharmaceutical industry in the United States United States statutes that abrogate Supreme Court decisions Pharmaceuticals policy United States federal health legislation United States federal controlled substances legislation
Wikipage page ID	6159258 (xsd:integer)
Wikipage revision ID	1124286132 (xsd:integer)
Link from a Wikipage to another Wikipage	Pharmaceutical industry in the United States Ronald Reagan Regulation of therapeutic goods Democratic Party (United States) United States statutes that abrogate Supreme Court decisions Inverse benefit law Drug Title 21 of the United States Code Pharmaceuticals policy United States federal health legislation Drug distribution Food and Drug Administration Prescription drug Counterfeit Federal Food, Drug and Cosmetic Act United States federal controlled substances legislation John Dingell Michigan United States federal government Pharmaceuticals dbr:Prescription_Drug_Amendments_of_1992
Link from a Wikipage to an external page	http://thomas.loc.gov/cgi-bin/bdquery/z%3Fd100:HR01207:@@@X http://www.gpo.gov/fdsys/pkg/STATUTE-102/pdf/STATUTE-102-Pg95.pdf https://www.fda.gov/regulatoryinformation/lawsenforcedbyfda/significantamendmentstothefdcact/prescriptiondrugmarketingactof1987/default.htm
sameAs	Prescription Drug Marketing Act Prescription Drug Marketing Act Prescription Drug Marketing Act Prescription Drug Marketing Act Prescription Drug Marketing Act
title amended	21 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Regulation_of_therapeutic_goods_in_the_United_States dbt:Short_description dbt:Usstat dbt:Infobox_U.S._legislation dbt:USbill dbt:Usc-title-chap
acts amended	Federal Food, Drug and Cosmetic Act
amendments	Prescription Drug Amendments of 1992 P.L. 102-353, 106 Stat. 941 (en)
cite public law	100 (xsd:integer)
effective date	1988-04-22 (xsd:date)
introducedby	John Dingell (en)
introduceddate	1987-02-24 (xsd:date)
introducedin	House (en)
passedbody	House (en) Senate (en)
passeddate	1987-05-04 (xsd:date) 1988-03-31 (xsd:date)
passedvote	passed voice vote (en)
public law url	http://www.gpo.gov/fdsys/pkg/STATUTE-102/pdf/STATUTE-102-Pg95.pdf
shorttitle	Prescription Drug Marketing Act of 1987 (en)
signeddate	1988-04-22 (xsd:date)
signedpresident	Ronald Reagan
committees	House Committee on Energy and Commerce (en)
enacted by	100 (xsd:integer)
has abstract	قانون تسويق الأدوية الموصوفة طبيًا (PDMA) لعام 1987 (القانون العام 100-293، المجلد 102 من مجموعة تشريعات الكونغرس الأمريكي 95) هو أحد قوانين الحكومة الفيدرالية للولايات المتحدة. ويوفر هذا القانون ضمانات قانونية تنظم توزيع الأدوية الموصوفة طبيًا للتأكد من توفير الدواء الآمن والفعال. وقد تمت صياغة هذا القانون لمكافحة بيع الدواء المزيف والمغشوش وذي العلامة التجارية المزيفة والأقل فعالية والمنتهي الصلاحية. وتم تمريره كنوع من أنواع الاستجابة لتطور سوق جملة غير قانوني (والمعروف باسم "السوق السوداء") للأدوية الموصوفة طبيًا. وقد خضع قانون تسويق الأدوية الموصوفة طبيًا للتعديل في تعديلات الأدوية الموصوفة طبيًا لعام 1992 (القانون العام 102-353، المجلد 106 من مجموعة تشريعات الكونغرس الأمريكي 941) في 26 أغسطس لعام 1992. وقد أصدرت إدارة الغذاء والدواء الأمريكية (FDA) قوانين لتنفيذ قانون تسويق الأدوية الموصوفة طبيًا عام 1990 (قانون اللوائح الفيدرالية رقم 21، الجزء 205) و(قانون اللوائح الفيدرالية رقم 21، الجزء 203) لعام 1999. (ar) The Prescription Drug Marketing Act (PDMA) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the United States federal government. It establishes legal safeguards for prescription drug distribution to ensure safe and effective pharmaceuticals and is designed to discourage the sale of counterfeit, adulterated, misbranded, sub potent, and expired prescription drugs. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs. The PDMA was modified by the Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26, 1992. The U.S. Food and Drug Administration (FDA) issued regulations implementing the PDMA in 1990 (21 C.F.R. Part 205) and 1999 (21 C.F.R. Part 203). (en)
leghisturl	http://thomas.loc.gov/cgi-bin/bdquery/z%3Fd100:HR01207:@@@X
longtitle	An Act to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on the distribution of drug samples, to ban certain resales of drugs by hospitals and other health care facilities, and for other purposes. (en)
sections amended	§§ 331, 353, 381 (en)
gold:hypernym	Law
prov:wasDerivedFrom	wikipedia-en:Prescription_Drug_Marketing_Act?oldid=1124286132&ns=0
page length (characters) of wiki page	4684 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Prescription_Drug_Marketing_Act
is Link from a Wikipage to another Wikipage of	Epedigree List of United States federal legislation, 1901–2001 List of abrogated United States Supreme Court decisions List of largest civil only pharmaceutical settlements List of largest pharmaceutical settlements Frank E. Young (physician) Consumer health laws PDMA Drug coupon History of the Food and Drug Administration Prescription drug

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (62 GB total memory, 54 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software